Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kalbe Farma | Jakarta | Salute | Prodotti farmaceutici | 78,15 Bln IDR | 25,6x | -4,02 | 1.690 IDR | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Jamu dan Farmasi Sido | Jakarta | Salute | Prodotti farmaceutici | 20,10 Bln IDR | 18,1x | 51,02 | 670 IDR | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,4% Rialzo | Fai l’upgrade a Pro+ | |
Tempo Scan Pacific | Jakarta | Salute | Prodotti farmaceutici | 11,82 Bln IDR | 9,1x | -9,12 | 2.620 IDR | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Soho Global | Jakarta | Salute | Prodotti farmaceutici | 8,76 Bln IDR | 18,8x | 0,48 | 685 IDR | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Enseval Putra | Jakarta | Salute | Prodotti farmaceutici | 6,72 Bln IDR | 9,5x | -1,4 | 2.480 IDR | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pyridam Farma | Jakarta | Salute | Prodotti farmaceutici | 2,92 Bln IDR | -10,8x | 0,19 | 260 IDR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Darya-Varia | Jakarta | Salute | Prodotti farmaceutici | 1,90 Bln IDR | 11,2x | 0,09 | 1.700 IDR | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Jakarta | Salute | Prodotti farmaceutici | 1,67 Bln IDR | 12,5x | -1,33 | 3.730 IDR | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ikapharmindo Putramas PT | Jakarta | Salute | Prodotti farmaceutici | 471,71 Mrd IDR | 36,5x | 280 IDR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Penta Valent PT | Jakarta | Salute | Prodotti farmaceutici | 413,16 Mrd IDR | 10,4x | 0,46 | 236 IDR | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Indofarma | Jakarta | Salute | Prodotti farmaceutici | 390,51 Mrd IDR | -0,6x | 0,01 | 126 IDR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Phapros | Jakarta | Salute | Prodotti farmaceutici | 322,56 Mrd IDR | -6,3x | 0,02 | 384 IDR | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Millennium Pharma | Jakarta | Salute | Prodotti farmaceutici | 200,02 Mrd IDR | 7,9x | -0,28 | 157 IDR | 13,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |